These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 16650744

  • 1. Temocillin in the treatment of Burkholderia cepacia infection in cystic fibrosis.
    Lekkas A, Gyi KM, Hodson ME.
    J Cyst Fibros; 2006 May; 5(2):121-4. PubMed ID: 16650744
    [Abstract] [Full Text] [Related]

  • 2. Temocillin in cystic fibrosis: a retrospective pilot study.
    Kent L, Bradley JM, France M, Döring G, Carryn S, Bradbury I, Rendall J, Jones A, Elborn JS.
    J Cyst Fibros; 2008 Nov; 7(6):551-4. PubMed ID: 18706868
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria.
    Hadjiliadis D, Steele MP, Chaparro C, Singer LG, Waddell TK, Hutcheon MA, Davis RD, Tullis DE, Palmer SM, Keshavjee S.
    J Heart Lung Transplant; 2007 Aug; 26(8):834-8. PubMed ID: 17692788
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience.
    De Soyza A, Meachery G, Hester KL, Nicholson A, Parry G, Tocewicz K, Pillay T, Clark S, Lordan JL, Schueler S, Fisher AJ, Dark JH, Gould FK, Corris PA.
    J Heart Lung Transplant; 2010 Dec; 29(12):1395-404. PubMed ID: 20810293
    [Abstract] [Full Text] [Related]

  • 7. Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis.
    Jones AM, Dodd ME, Govan JR, Barcus V, Doherty CJ, Morris J, Webb AK.
    Thorax; 2004 Nov; 59(11):948-51. PubMed ID: 15516469
    [Abstract] [Full Text] [Related]

  • 8. The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre.
    Dobbin C, Maley M, Harkness J, Benn R, Malouf M, Glanville A, Bye P.
    J Hosp Infect; 2004 Apr; 56(4):277-82. PubMed ID: 15066737
    [Abstract] [Full Text] [Related]

  • 9. Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis.
    Kitt H, Lenney W, Gilchrist FJ.
    BMC Pharmacol Toxicol; 2016 Mar 28; 17():14. PubMed ID: 27018049
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Successful treatment of cepacia syndrome with combination nebulised and intravenous antibiotic therapy.
    Weidmann A, Webb AK, Dodd ME, Jones AM.
    J Cyst Fibros; 2008 Sep 28; 7(5):409-11. PubMed ID: 18356119
    [Abstract] [Full Text] [Related]

  • 12. Temocillin and cystic fibrosis: outcome of intravenous administration in patients infected with Pseudomonas cepacia.
    Taylor RF, Gaya H, Hodson ME.
    J Antimicrob Chemother; 1992 Mar 28; 29(3):341-4. PubMed ID: 1375595
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Burkholderia gladioli: five year experience in a cystic fibrosis and lung transplantation center.
    Kennedy MP, Coakley RD, Donaldson SH, Aris RM, Hohneker K, Wedd JP, Knowles MR, Gilligan PH, Yankaskas JR.
    J Cyst Fibros; 2007 Jul 28; 6(4):267-73. PubMed ID: 17137846
    [Abstract] [Full Text] [Related]

  • 15. The relationship of clinical and inflammatory markers to outcome in stable patients with cystic fibrosis.
    Downey DG, Martin SL, Dempster M, Moore JE, Keogan MT, Starcher B, Edgar J, Bilton D, Elborn JS.
    Pediatr Pulmonol; 2007 Mar 28; 42(3):216-20. PubMed ID: 17238189
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Risk factors for Burkholderia cepacia complex colonization and infection among patients with cystic fibrosis.
    Walsh NM, Casano AA, Manangan LP, Sinkowitz-Cochran RL, Jarvis WR.
    J Pediatr; 2002 Oct 28; 141(4):512-7. PubMed ID: 12378190
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex.
    Herasimenka Y, Cescutti P, Impallomeni G, Campana S, Taccetti G, Ravenni N, Zanetti F, Rizzo R.
    J Cyst Fibros; 2007 Apr 28; 6(2):145-52. PubMed ID: 16860003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.